… in vitro studies of 18 F-FDG uptake and mTOR inhibition in NSCLC cells. … F-FDG uptake in
lung cancer. The results of the present study revealed that the amount of 18 F-FDG uptake was …

… evidence supporting the role of 18F-FDG PET are discussed. … Lung cancer remains
one of the major causes of cancer-… form of lung cancer is non–small cell lung cancer (NSCLC). …

… of residual tumor FDG uptake after induction therapy is, like tumor FDG uptake at diagnosis,
a … Patients in whom treatment results in complete resolution of prior FDG uptake have been …

… In conclusion, FDG-PET has potential for use as a simplified staging and re-staging tool
for small cell lung cancer, if these results are confirmed in a larger clinical trial. …

… At this moment the use of FDG-PET in these … role of FDG-PET in the diagnosis of lung
nodules and masses, and in locoregional and extrathoracic staging of non-small cell lung cancer. …

… 32 non—smallcell lung cancers and had The goals of this study were to correlate FDG
uptake with cell proliferation and cellular density in non—smallcell lung cancer. Methods: Thirty-…

… between FDG uptake and histopathology of the tumor, as the SUV was significantly higher
in squamous cell carcinomas compared to adenocarcinomas or large cell carcinomas. This …

… In previous clinical reports, the value of FDGPET in the management of patients with …
non-small cell lung cancer (NSCLC) has been shown [4±6]. In this study, the use of FDG-PET for the …

… the tumor maxSUV, … FDG uptake with respect to cancer stage and prognosis, we sought to
complete our characterization of FDG uptake in NSCLC with an analysis with respect to tumor …

… tumor types of nonsmall cell lung cancer can be identified by variance in FDGPET standard
uptake … Staging FDG-PET and CT scans of 81 patients (34 men and 47 women, average age …